Identification of druggable oncogenic gene fusions and a novel mechanism of drug resistance in lung cancer

被引：0
|
作者：
Nakaoku, Takashi [1 ]
Kohno, Takashi [1 ,2 ]
机构：
[1] Natl Canc Ctr Res, Div Genome Biol, Tokyo, Japan
[2] Natl Canc Ctr, EPOC, Div Translat Genom, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
YIA-7
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [31] Pathological transition as the arising mechanism for drug resistance in lung cancer
    Chen, Yueqing
    Tang, Waiying Yvonne
    Tong, Xinyuan
    Ji, Hongbin
    CANCER COMMUNICATIONS, 2019, 39 (01)
  • [32] Performance of Retrospective Screening of Biobank Resection Specimens for Identification of Oncogenic Fusions in Lung Adenocarcinoma
    Desmeules, P.
    Bastien, N.
    Boudreau, D.
    Orain, M.
    Couture, C.
    Joubert, P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S88 - S88
  • [33] NTRK1 gene fusions as a novel oncogene target in lung cancer.
    Doebele, Robert Charles
    Vaishnavi, Aria
    Capelletti, Marzia
    Le, Anh T.
    Kako, Severine
    Butaney, Mohit
    Mahale, Sakshi
    Aisner, Dara L.
    Haas, Julia
    Andrews, Steven W.
    Lipson, Doron
    Stephens, Philip J.
    Varella-Garcia, Marileila
    Janne, Pasi Antero
    Miller, Vincent A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Novel gene fusions found in cervical cancer
    Ling, Yiwei
    Okuda, Shujiro
    EBIOMEDICINE, 2018, 38 : 13 - 14
  • [35] Identification of novel carboplatin resistance gene in ovarian cancer
    Wei, Han
    She, Yun
    Lu, Tao
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population
    Zhao, Ruiying
    Yao, Feng
    Xiang, Chan
    Zhao, Jikai
    Shang, Zhanxian
    Guo, Lianying
    Ding, Wenjie
    Ma, Shengji
    Yu, Anbo
    Shao, Jinchen
    Zhu, Lei
    Han, Yuchen
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2021, 7 (04): : 375 - 384
  • [37] Therapeutic strategy for targeting recurrent oncogenic kinase gene fusions in prostate cancer
    Turaga, Ravi Chakra
    Murali, Shivani Jagannathan
    Karre, Bharath Kumar
    Ivan, Cristina
    Sima, Chao
    Abera, Asfetaw
    Radovich, Milan
    O'Neill, Heather
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Identification of novel epitopes, drug resistance markers and drug resistance mechanism using alternative splicing studies
    Casagrande, Anne-Sophie
    Mahe, Florence
    Kotraiah, Vin
    Pando, Matt
    Desire, Laurent
    CANCER RESEARCH, 2011, 71
  • [39] Switch to MET oncogene dependence as a novel mechanism of drug resistance in EGFR-mutant lung cancer
    Eser, Pinar O.
    Paranal, Raymond M.
    Poitras, Michael J.
    Xu, Man
    Wang, Stephen
    Ogino, Atsuko
    Choi, Jihyun
    Missios, Pavlos
    Haikala, Heidi M.
    Son, Jieun
    Lin, Mika
    Yanagita, Masahiko
    Gokhale, Prafulla C.
    Daley, George Q.
    Janne, Pasi A.
    CANCER RESEARCH, 2019, 79 (13)
  • [40] EGFR Fusions as Novel Therapeutic Targets in Lung Cancer
    Konduri, Kartik
    Gallant, Jean-Nicolas
    Chae, Young Kwang
    Giles, Francis J.
    Gitlitz, Barbara J.
    Gowen, Kyle
    Ichihara, Eiki
    Owonikoko, Taofeek K.
    Peddareddigari, Vijay
    Ramalingam, Suresh S.
    Reddy, Satyanarayan K.
    Eaby-Sandy, Beth
    Vavala, Tiziana
    Whiteley, Andrew
    Chen, Heidi
    Yan, Yingjun
    Sheehan, Jonathan H.
    Meiler, Jens
    Morosini, Deborah
    Ross, Jeffrey S.
    Stephens, Philip J.
    Miller, Vincent A.
    Ali, Siraj M.
    Lovly, Christine M.
    CANCER DISCOVERY, 2016, 6 (06) : 601 - 611
12345